Skip to main content

Table 2 Summary of primary outcome measures and expected results

From: Fenofibrate in the management of AbdoMinal aortic anEurysm (FAME): study protocol for a randomised controlled trial

Primary outcome

Measurement method

Estimated outcomes

Placebo

Fenofibrate

AAA-wall OPN concentration (pg/mg)

ELISA

210 ± 145

84 ± 87

AAA-wall macrophages (per mm2 section)

IHC

4.9 ± 1.8

2.4 ± 1.8

Serum OPN concentration (ng/mL)

ELISA

77 ± 32

46 ± 32

  1. AAA abdominal aortic aneurysm, ELISA enzyme-linked immunosorbent assay, IHC immunohistochemistry, OPN osteopontin
Back to article page

Trials

ISSN: 1745-6215